By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Transdel Pharmaceuticals, Inc. 

4225 Executive Square
Suite 460
La Jolla  California  92037  U.S.A.
Phone: 858-457-5300 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Transdel Pharmaceuticals, Inc. (TDLP.OB) Files for Chapter 11, Agrees to Sell Lead Drug Candidate to Cardium Therapeutics, Inc. (CXM) 6/27/2011 8:22:35 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) Announces Exploration of Strategic Alternatives 2/1/2011 9:07:23 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President 10/21/2010 7:37:05 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) to Present at Rodman & Renshaw 12th Annual Healthcare Conference 9/7/2010 12:15:38 PM
Transdel Pharmaceuticals, Inc. (TDLP.OB) Presents Phase 3 Study Data on Ketotransdel(R) at World Pain Congress in Montreal, Canada 9/2/2010 11:12:53 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) Reports Second Quarter and Year-to-Date 2010 Results 8/12/2010 9:03:12 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) to Present at 2010 Southern California Investor Conference 8/11/2010 8:30:37 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) to Present at OneMedForum New York 2010 6/24/2010 10:34:21 AM
Transdel Pharmaceuticals, Inc. (TDLP.OB) Reports First Quarter 2010 Results 5/13/2010 9:28:58 AM
Data from Transdel Pharmaceuticals, Inc. (TDLP.OB)'s Phase 3 Study to be Presented at 13th World Congress on Pain 5/4/2010 12:09:11 PM
1234
//-->